RxDoctor Payments Data
★ My doctorsLook up a doctor →

Michelle Rampersad

Oncology · Sebring, FLNPI 1518154236

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Incyte Corporation accounts for 68.1% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2023 at $10,412 and has fallen 71.1% since, to $3,006 in 2025. Among oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,018in general payments, 2019–2025

Across 582 payments — averaging $58.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$23K
  • Johnson & Johnson$1K
  • Novartis$1K
  • AstraZeneca$839
  • Astellas Pharma US Inc$567
  • Lilly USA, LLC$552
  • plus $6K from 54 others

What the payments were for

  • Consulting fees$3,34510%
  • Speaking & faculty fees$14,44042%
  • Travel & lodging$3,79911%
  • Food & beverage$11,28833%
  • Education$1,1463%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation78$23,180
Johnson & Johnson(2 entities)52$1,343
Novartis63$1,027
AstraZeneca(2 entities)36$839
Astellas Pharma US Inc14$567
Lilly USA, LLC22$552
Daiichi Sankyo Inc.22$506
Bayer29$483
Pfizer20$441
Merck21$434
Sanofi18$370
Bristol Myers Squibb12$341
Sobi, Inc11$309
Eisai Inc.14$281
Takeda Pharmaceuticals U.S.A., Inc.12$250
Genentech USA, Inc.11$199
Seagen Inc.6$185
GSK8$168
E.r. Squibb & Sons, L.L.C.9$152
Pharmacosmos Therapeutics Inc.7$139
Gilead(2 entities)8$134
Tersera Therapeutics LLC6$127
Array Biopharma Inc6$123
Jazz Pharmaceuticals Inc.6$106
Regeneron Healthcare Solutions, Inc.5$105
AVEO Pharmaceuticals, Inc.5$103
Deciphera Pharmaceuticals Inc.4$84
Amgen4$75
Stemline Therapeutics Inc.4$68
Karyopharm Therapeutics Inc.3$66
Ipsen Biopharmaceuticals, Inc3$66
Boehringer Ingelheim3$64
G1 Therapeutics, Inc.3$54
Sumitomo Pharma America, Inc.3$53
Agios Pharmaceuticals, Inc.3$52
Morphosys, US Inc.3$50
AbbVie2$49
Geron Corporation2$48
Pharmacyclics LLC, An Abbvie Company2$46
Pharmaessentia USA Corporation2$45
Foundation Medicine, Inc.2$41
Global Blood Therapeutics, Inc.2$39
Mirati Therapeutics, Inc.2$38
EMD Serono, Inc.2$38
Genmab U.S., Inc.2$37
Rigel Pharmaceuticals, Inc.2$37
Puma Biotechnology, Inc.2$37
Kyowa Kirin, Inc.2$32
Angiodynamics, Inc.1$27
Myriad Genetic Laboratories, Inc.1$23
Emmaus Medical, Inc.1$22
Apellis Pharmaceuticals, Inc.1$21
Azurity Pharmaceuticals, Inc.1$21
Tolmar, Inc.1$21
Pharmaand GmbH1$21
Alnylam Pharmaceuticals Inc.1$20
Springworks Therapeutics, Inc.1$19
Novocure Inc.1$19
Verity Pharmaceuticals Inc.1$19
CTI Biopharma Corp.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,018 in reported general payments places this provider in the 95th percentile of 24 oncology providers in Florida.

See all oncology providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sunitinib Malate11$15,443
Anastrozole38$1,311
Hydroxyurea30$774
Ondansetron OdtOndansetron14$463
Letrozole20$368
Dexamethasone12$211
Fluoxetine Hcl13$94
Allopurinol13$82

Paid to pharmacies, not to this prescriber.

Other oncology in Sebring

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →